Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Active substance : telbivudine
  • Topics : Medical imaging
  • Topics : Liver diseases
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Medical imaging (1)
      • Biology (laboratory tests) (1)
      • Cell and tissue pathology (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Sexually transmitted diseases (1)
      • Virus diseases (1)
    • Digestive system diseases (1)
    • Plus ...
      • Liver diseases (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Language
  • Français (1)
Active substance
  • alanine (1)
  • alcool (1)
  • fer (1)
  • galactose (1)
  • lamivudine (1)
  • phosphore (1)
  • soufre (1)
  • telbivudine (1)

Drugs, devices and medical acts - 1 result

  • Assessment of non-invasive methods for measuring liver fibrosis in chronic hepatitis B. Initial assessment and follow-up of non-treated adult patients - INAHTA Brief

    Health technology assessment - Posted on 19/6/2014
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
QadLFBDhC1rmmZm9